Overview
Constance Roche is a Nurse Practitioner in Boston, Massachusetts. Ms. Roche is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are BRCA Positive Breast Cancer and HER2 Negative Breast Cancer.
Her clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
Locations
The General Hospital Corporation
Erin Sullivan is a Nurse Practitioner in Boston, Massachusetts. Ms. Sullivan is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are BRCA Positive Breast Cancer and HER2 Negative Breast Cancer.
York Hospital
Rebecca Freligh is a Nurse Practitioner in York, Maine. Ms. Freligh has been practicing medicine for over 9 years and is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Smoldering Multiple Myeloma.
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
Zinat Nassirzadeh is a Nurse Practitioner in Brighton, Massachusetts. Ms. Nassirzadeh has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are BRCA Positive Breast Cancer and HER2 Negative Breast Cancer. Ms. Nassirzadeh is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- BRCA Positive Breast CancerMs. Roche isAdvanced. Learn about BRCA Positive Breast Cancer.
- HER2 Negative Breast CancerMs. Roche isAdvanced. Learn about HER2 Negative Breast Cancer.